KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Equity Ratio (2018 - 2021)

Historic Equity Ratio for BioNTech SE (BNTX) over the last 4 years, with Q4 2021 value amounting to 0.75.

  • BioNTech SE's Equity Ratio rose 2698.4% to 0.75 in Q4 2021 from the same period last year, while for Dec 2021 it was 0.75, marking a year-over-year increase of 2698.4%. This contributed to the annual value of 0.75 for FY2021, which is 2698.4% up from last year.
  • Per BioNTech SE's latest filing, its Equity Ratio stood at 0.75 for Q4 2021, which was up 2698.4% from 0.59 recorded in Q4 2020.
  • Over the past 5 years, BioNTech SE's Equity Ratio peaked at 0.75 during Q4 2021, and registered a low of 0.41 during Q4 2018.
  • For the 4-year period, BioNTech SE's Equity Ratio averaged around 0.59, with its median value being 0.61 (2019).
  • As far as peak fluctuations go, BioNTech SE's Equity Ratio surged by 5131.05% in 2019, and later crashed by 437.12% in 2020.
  • Quarter analysis of 4 years shows BioNTech SE's Equity Ratio stood at 0.41 in 2018, then soared by 51.31% to 0.62 in 2019, then decreased by 4.37% to 0.59 in 2020, then rose by 26.98% to 0.75 in 2021.
  • Its last three reported values are 0.75 in Q4 2021, 0.59 for Q4 2020, and 0.62 during Q4 2019.